Table 2. Primary and Secondary Outcomesa.
Outcome | Patient group | OR (95% CI) | P value | |
---|---|---|---|---|
ON101 (n = 122) | Absorbent dressing (n = 114) | |||
Complete healing, No. (%) | ||||
FAS | 74 (60.7) | 40 (35.1) | 2.84 (1.66-4.84) | <.001b |
mITT | 73 (61.9) | 38 (33.9) | 3,15 (1.82-5.43) | <.001b |
Secondary | ||||
Change in WSA from baseline to visit 10, mean (SD), % | −78.0 (42.6) | −78.0 (34.9) | NA | .89 |
Incidence of patients with 50% reduction in WSA on visit 10, No. (%) | 101 (82.8) | 98 (86.0) | 0.80 (0.39-1.62) | .53b |
Incidence of wound infection | 6 (4.9) | 7 (6.1) | NA | .78 |
Ulcer recurrence, No. (%)c | 15 (20.3) | 7 (17.5) | NA | .81 |
Safety | ||||
Patients with TEAEs, No. (%) | 76 (62.3) | 77 (67.5) | NA | .42 |
No. of TEAEs | 207 | 235 | NA | |
Related TEAEs | ||||
Patients, No. (%) | 7 (5.7) | 5 (4.4) | NA | .77 |
No. of events | 11 | 5 | NA | NA |
Serious TEAEs | ||||
Patients, No. (%) | 14 (11.5) | 9 (7.9) | NA | .39 |
No. of events | 24 | 14 | NA | NA |
Related serious TEAEs in events, No. (%) | 0 | 1 (0.9) | NA | <.48 |
TEAE leading to death, No. | 0 | 0 | NA | NA |
Subgroup analysis | ||||
Wound closure, No./total No. (%) | ||||
HbA1c level | ||||
<9% | 59/90 (65.6) | 33/82 (40.2) | 2.81 (1.50-5.26) | <.001b |
≥9% | 15/32 (46.9) | 7/32 (21.9) | 3.14 (1.04-9.50) | .04b |
Ulcer size, cm2 | ||||
1-5 | 55/88 (62.5) | 31/77 (40.3) | 2.46 (1.31-4.61) | .005b |
>5 | 18/33 (54.5) | 8/36 (22.2) | 4.09 (1.42-11.80) | .009b |
Ulcer duration, mo | ||||
<6 mo | 62/86 (72.1) | 36/79 (45.6) | 3.07 (1.59-5.95) | <.001b |
≥6 mo | 12/36 (33.3) | 4/35 (11.4) | 3.99 (1.09-14.63) | .04b |
Abbreviations: FAS, full-analysis set; HbA1c, glycated hemoglobin; mITT, modified intent-to-treat; NA, not applicable; OR, odds ratio; TEAEs, treatment-emergent adverse events; WSA, wound (ulcer) surface area.
The absorbent dressing used was Hydrofiber (ConvaTec Ltd).
Calculated using a logistic regression model. Treatment was the main exposure variable; the baseline wound size in cm2 and Wagner grade were covariates.
Ulcer recurrence was recorded once the ulcer had healed completely and was observed during the follow-up period.